PE20021145A1 - Composicion farmaceutica finamente autoemulsificable - Google Patents
Composicion farmaceutica finamente autoemulsificableInfo
- Publication number
- PE20021145A1 PE20021145A1 PE2002000315A PE2002000315A PE20021145A1 PE 20021145 A1 PE20021145 A1 PE 20021145A1 PE 2002000315 A PE2002000315 A PE 2002000315A PE 2002000315 A PE2002000315 A PE 2002000315A PE 20021145 A1 PE20021145 A1 PE 20021145A1
- Authority
- PE
- Peru
- Prior art keywords
- fatty acid
- amino
- valdeco
- organic
- substituted
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 OLEIC Chemical class 0.000 abstract 4
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 3
- 229930195729 fatty acid Natural products 0.000 abstract 3
- 239000000194 fatty acid Substances 0.000 abstract 3
- 150000004665 fatty acids Chemical class 0.000 abstract 3
- 239000002904 solvent Substances 0.000 abstract 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 abstract 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 abstract 1
- 102000010907 Cyclooxygenase 2 Human genes 0.000 abstract 1
- 108010037462 Cyclooxygenase 2 Proteins 0.000 abstract 1
- BZKFMUIJRXWWQK-UHFFFAOYSA-N Cyclopentenone Chemical compound O=C1CCC=C1 BZKFMUIJRXWWQK-UHFFFAOYSA-N 0.000 abstract 1
- 206010019233 Headaches Diseases 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 abstract 1
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical compound O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 abstract 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 abstract 1
- 229960000590 celecoxib Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 231100000869 headache Toxicity 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- DAZXVJBJRMWXJP-UHFFFAOYSA-N n,n-dimethylethylamine Chemical compound CCN(C)C DAZXVJBJRMWXJP-UHFFFAOYSA-N 0.000 abstract 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28438101P | 2001-04-17 | 2001-04-17 | |
| US32695201P | 2001-10-04 | 2001-10-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20021145A1 true PE20021145A1 (es) | 2003-01-16 |
Family
ID=26962574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000315A PE20021145A1 (es) | 2001-04-17 | 2002-04-16 | Composicion farmaceutica finamente autoemulsificable |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20030105141A1 (enExample) |
| EP (1) | EP1379279A1 (enExample) |
| JP (1) | JP2004530669A (enExample) |
| KR (1) | KR20040018355A (enExample) |
| CN (1) | CN1516601A (enExample) |
| AR (1) | AR033221A1 (enExample) |
| AU (1) | AU2002305175B2 (enExample) |
| BR (1) | BR0208994A (enExample) |
| CA (1) | CA2444220A1 (enExample) |
| CZ (1) | CZ20032792A3 (enExample) |
| EA (1) | EA008103B1 (enExample) |
| IL (1) | IL158201A0 (enExample) |
| MX (1) | MXPA03009411A (enExample) |
| NO (1) | NO20034629L (enExample) |
| NZ (1) | NZ528741A (enExample) |
| PE (1) | PE20021145A1 (enExample) |
| PL (1) | PL364524A1 (enExample) |
| WO (1) | WO2002083177A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7115565B2 (en) * | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| EP1344523A1 (en) * | 2002-03-11 | 2003-09-17 | Warner-Lambert Company | Ibuprofen solution for hard gelatin capsules |
| IL164163A0 (en) * | 2002-04-09 | 2005-12-18 | Pharmacia Corp | Process for preparing a finely self-emulsifiable pharmaceutical composition |
| WO2004073492A2 (en) * | 2003-02-14 | 2004-09-02 | Massachusetts Eye And Ear Infirmary | Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof |
| JP5296314B2 (ja) * | 2003-07-17 | 2013-09-25 | バナー ファーマキャップス，インコーポレイティド | 制御放出製剤 |
| EP1510206A1 (en) * | 2003-08-29 | 2005-03-02 | Novagali Pharma SA | Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs |
| US20060002989A1 (en) * | 2004-06-10 | 2006-01-05 | Ahmed Salah U | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
| SG164378A1 (en) | 2005-02-17 | 2010-09-29 | Synta Pharmaceuticals Corp | Compounds for the treatment of proliferative disorders |
| CN101351196B (zh) | 2005-10-26 | 2013-07-03 | 班纳制药公司 | 作为胶囊填充物的基于亲脂性载体的双重控释基质系统 |
| US8333989B2 (en) | 2005-10-26 | 2012-12-18 | Banner Pharmacaps, Inc. | Hydrophilic vehicle-based dual controlled release matrix system |
| ES2382026T3 (es) * | 2007-09-27 | 2012-06-04 | Wockhardt Limited | Composiciones farmacéuticas autoemulsionantes de reína o diacereína |
| UA102120C2 (ru) * | 2008-12-03 | 2013-06-10 | Астеллас Дойчленд Гмбх | Пероральная форма дозирования бендамустина |
| ES2661812T3 (es) | 2009-10-16 | 2018-04-04 | Mochida Pharmaceutical Co., Ltd. | Composiciones |
| CN103037851A (zh) * | 2010-06-02 | 2013-04-10 | 安斯泰来德国有限公司 | 苯达莫司汀的口服剂型 |
| JO3659B1 (ar) | 2010-06-02 | 2020-08-27 | Astellas Deutschland Gmbh | أشكال جرعات بينداموستين عن طريق الفم وإستخداماته العلاجية |
| EP2392319A1 (en) * | 2010-06-04 | 2011-12-07 | Laboratorios Del. Dr. Esteve, S.A. | Pharmaceutical compositions of co-crystals of tramadol and coxibs |
| US8951514B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels |
| US9119826B2 (en) | 2011-02-16 | 2015-09-01 | Pivotal Therapeutics, Inc. | Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels |
| US8952000B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
| TW201322979A (zh) * | 2011-10-18 | 2013-06-16 | 拉夸里亞創藥股份有限公司 | 醫藥組成物 |
| CN105007947B (zh) * | 2013-01-14 | 2019-02-15 | 因佛斯特医疗有限公司 | 固溶体组合物及其在心血管疾病中的用途 |
| KR20150129664A (ko) * | 2013-02-04 | 2015-11-20 | 인퍼스트 헬스케어 리미티드 | 만성 염증 및 염증성 질병을 치료하기 위한 조성물 및 방법 |
| CN105491886B (zh) | 2013-08-27 | 2019-01-29 | V·沃道里斯 | 苯达莫司汀医药组合物 |
| CN109477010B (zh) | 2016-07-05 | 2021-07-23 | 戈登可再生能源有限公司 | 用于将废弃塑料转化成燃料的系统和工艺 |
| US12213510B2 (en) | 2019-09-11 | 2025-02-04 | Nicoventures Trading Limited | Pouched products with enhanced flavor stability |
| CN113750043A (zh) * | 2021-09-18 | 2021-12-07 | 山东省药学科学院 | 一种塞来昔布自乳化口服液及其制备方法 |
| WO2024142089A1 (en) * | 2022-12-27 | 2024-07-04 | Cipla Limited | Injectable compositions of celecoxib |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RO118291B1 (ro) * | 1993-11-30 | 2003-04-30 | Searle & Co | Derivati de pirazol 1,3,4,5 - tetrasubstituiti si compozitie farmaceutica care ii contine |
| US5571536A (en) * | 1995-02-06 | 1996-11-05 | Nano Systems L.L.C. | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
| US5733909A (en) * | 1996-02-01 | 1998-03-31 | Merck Frosst Canada, Inc. | Diphenyl stilbenes as prodrugs to COX-2 inhibitors |
| AU750125B2 (en) * | 1997-08-27 | 2002-07-11 | Hexal Ag | New pharmaceutical compositions of meloxicam with improved solubility and bioavailability |
| US6025353A (en) * | 1997-11-19 | 2000-02-15 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| SA99191255B1 (ar) * | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
| MY120279A (en) * | 2000-05-26 | 2005-09-30 | Pharmacia Corp | Use of a celecoxib composition for fast pain relief |
| AU2001282886A1 (en) * | 2000-07-13 | 2002-01-30 | Pharmacia Corporation | Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain |
-
2002
- 2002-04-09 US US10/119,129 patent/US20030105141A1/en not_active Abandoned
- 2002-04-12 EP EP02733979A patent/EP1379279A1/en not_active Withdrawn
- 2002-04-12 EA EA200301019A patent/EA008103B1/ru not_active IP Right Cessation
- 2002-04-12 JP JP2002580978A patent/JP2004530669A/ja not_active Withdrawn
- 2002-04-12 WO PCT/US2002/011689 patent/WO2002083177A1/en not_active Ceased
- 2002-04-12 PL PL02364524A patent/PL364524A1/xx not_active Application Discontinuation
- 2002-04-12 AU AU2002305175A patent/AU2002305175B2/en not_active Ceased
- 2002-04-12 BR BR0208994-7A patent/BR0208994A/pt not_active IP Right Cessation
- 2002-04-12 NZ NZ528741A patent/NZ528741A/en unknown
- 2002-04-12 CA CA002444220A patent/CA2444220A1/en not_active Abandoned
- 2002-04-12 KR KR10-2003-7013651A patent/KR20040018355A/ko not_active Ceased
- 2002-04-12 IL IL15820102A patent/IL158201A0/xx unknown
- 2002-04-12 CN CNA028120787A patent/CN1516601A/zh active Pending
- 2002-04-12 CZ CZ20032792A patent/CZ20032792A3/cs unknown
- 2002-04-12 MX MXPA03009411A patent/MXPA03009411A/es not_active Application Discontinuation
- 2002-04-16 PE PE2002000315A patent/PE20021145A1/es not_active Application Discontinuation
- 2002-04-17 AR ARP020101396A patent/AR033221A1/es unknown
-
2003
- 2003-10-16 NO NO20034629A patent/NO20034629L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20034629D0 (no) | 2003-10-16 |
| WO2002083177A1 (en) | 2002-10-24 |
| EP1379279A1 (en) | 2004-01-14 |
| EA200301019A1 (ru) | 2004-06-24 |
| IL158201A0 (en) | 2004-05-12 |
| CN1516601A (zh) | 2004-07-28 |
| MXPA03009411A (es) | 2004-01-29 |
| NO20034629L (no) | 2003-12-10 |
| CZ20032792A3 (cs) | 2004-04-14 |
| CA2444220A1 (en) | 2002-10-24 |
| US20030105141A1 (en) | 2003-06-05 |
| PL364524A1 (en) | 2004-12-13 |
| BR0208994A (pt) | 2004-04-27 |
| NZ528741A (en) | 2005-09-30 |
| KR20040018355A (ko) | 2004-03-03 |
| AU2002305175B2 (en) | 2007-07-12 |
| JP2004530669A (ja) | 2004-10-07 |
| EA008103B1 (ru) | 2007-04-27 |
| AR033221A1 (es) | 2003-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5580835A2 (es) | Nuevas formulaciones analogas de ciclosporina | |
| AR033221A1 (es) | Composicion farmaceutica finamente autoemulsionable | |
| BR0309138A (pt) | Processo para a preparação de uma composição farmacêutica finamente auto-emulsionável | |
| AR045906A1 (es) | Composicion farmaceutica para mejorar la solubilidad de farmacos hidrofobicos | |
| BR0212028A (pt) | Sistema terapêutico transdérmico (tts) com a substância ativa fentanila | |
| AR039537A1 (es) | Sistemas de cebo rodenticidas | |
| ATE497384T1 (de) | Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen | |
| BRPI0511704A (pt) | formulações aquosas com pouca espuma como defensivo para plantas | |
| NO20025629D0 (no) | Formulering | |
| MX9306303A (es) | Derivados de acidos carboxilicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion. | |
| NZ596657A (en) | Self micro-emulsifying oral pharmaceutical composition of hydrophilic drug and preparation method thereof | |
| AR056808A1 (es) | Formulacion de aceite en agua de avermectinas | |
| NO20024194D0 (no) | Nytt selvemulgerende legemiddelavleveringssystem | |
| DK1170003T3 (da) | Selvemulgerende lægemiddelleveringssystem til fedtoplöselige lægemidler | |
| CO4930324A1 (es) | Composicion quimica que contiene un sistema preservativo y metodo para elaborar y usar tal composicion | |
| AR037131A1 (es) | Formulaciones de jarabe de ribavirina | |
| DE60121432D1 (de) | Iod-propylenglycol-zitzentauchbad | |
| PE20050699A1 (es) | Sistemas emulsionantes que contienen derivados de azetidina | |
| PA8576601A1 (es) | Formulacion parenteral liquida estable de parecoxib | |
| FR3091485B1 (fr) | Capsule pour composition d’aromathérapie et dispositif de diffusion pour l’utilisation d’une telle capsule | |
| ATE450241T1 (de) | Dünnflüssige w/o emulsionen | |
| PE20171305A1 (es) | Formulaciones inyectables de paracetamol | |
| PE20050287A1 (es) | Sistemas semi-solidos que contienen derivados de azetidina | |
| PE20191462A1 (es) | Composicion liquida que contiene pradofloxacina | |
| CL2021001742A1 (es) | Sistema emulsionante para composiciones agrícolas que comprenden un aceite pesticida natural |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |